Sponsored by Cagent Vascular

The Serranator® Alto PTA Serration Balloon Catheter

 

The Serranator® Alto PTA Serration Balloon Catheter (Figure 1) is an over-the-wire balloon dilatation catheter designed to perform percutaneous transluminal angioplasty for peripheral vasculature as described in the indications for use statement. The Serranator® Alto has a nylon semicompliant balloon with four embedded external serrated metal strips. The serrated strips are designed to create linear, interrupted scoring (Figure 2) along the endoluminal surface during balloon angioplasty.

Figure 1. Close-up of the Serranator® Alto balloon and its four embedded external metal serrated strips.

Figure 2. Scanning electron microscopy (SEM) images approximately 5X (A) and 10X (B) of porcine femoral artery surface 7 days after Serranator®. Linear, interrupted serrations demonstrate controlled media exposure, circumferential expansion (between each serration), and neointimal healing.

Indications For Use

The Serranator® Alto PTA Serration Balloon Catheter is intended for dilatation of lesions in the iliac, femoral, iliofemoral, and popliteal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. Not for use in the coronary or neuro-vasculature. The Serranator® Alto received 510(k) clearance from the US Food and Drug Administration in February 2017.

The Serranator® Bass, currently in development, will be intended for below-the-knee arteries.

Product Specifications

• 0.018” guidewire compatible

• 6 F sheath compatible

• Semicompliant balloon

• 150 cm catheter length

• 4.0, 5.0, and 6.0 mm balloon diameters

• 40, 80, and 120 mm balloon lengths

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.